🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hangzhou
Clinical trial register · China

Clinical Trials in Hangzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Hangzhou 31 Qingdao 1 Ningbo 1 Tianjin 1 Wenzhou 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine373 Zhejiang University104 First Affiliated Hospital of Zhejiang University103 AstraZeneca76 Zhejiang Cancer Hospital63 Clear sponsor filter
Site location
Hangzhou31 Qingdao1 Ningbo1 Tianjin1 Wenzhou1
All 8 locations
Target enrolment
to

Trials with a site in Hangzhou

31 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
By invitation
Study on the Efficacy and Safety of Different Doses of PEG-rhG-CSF for Primary Prevention of Febrile Neutropenia
NCT07829276Malignant Tumor
Zhejiang Provincial People's Hospital
Observational
350
Hangzhou
2026-11-01
Not yet open
Spinal Cord Stimulation Combined With Motor Imagery Brain-Computer Interface for Chronic Post-Stroke Upper Limb Motor Dysfunction
NCT07686822Chronic Stroke
Zhejiang Provincial People's Hospital
Not applicable
66
Hangzhou
2026-09
Recruiting
Allogeneic WTX-212C in Advanced Solid Tumors
NCT07556653Advanced Solid Tumors
Zhejiang Provincial People's Hospital
Phase EARLY_PHASE1
24
Hangzhou
2026-06-26
By invitation
Neoadjuvant Treatment of Locally Advanced HNSCC With Pertuzumab Combined With Lenvatinib.
NCT07550972Squamous Cell Carcinoma of the Head and Neck
Zhejiang Provincial People's Hospital
Phase 2
30
Hangzhou
2026-05-01
Recruiting
Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis
NCT07491016Telitacicept, Treatment Compliance, Rheumatoid Arthritis
Zhejiang Provincial People's Hospital
Observational
30
Hangzhou
2026-03-01
Not yet open
Xiaojin Pill/Neixiao Luoli Pill for the Treatment of Thyroid Nodules
NCT07340177Thyroid Nodules
Zhejiang Provincial People's Hospital
Phase 4
108
Hangzhou
2026-03
Recruiting
LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study
NCT07312422Pancreatic Cancer, PD-L1, PD-1 Inhibitor, LDRT
DrugsFolfirinox·Pucotenlimab
Zhejiang Provincial People's Hospital
Phase 1/2
10
Hangzhou
2025-09-30
Recruiting
Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer
NCT07068542Advanced Thyroid Carcinoma, Radioiodine-refractory Differentiated Thyroid Cancer, Poorly Differentiated Thyroid Carcinoma
DrugsSacituzumab tirumotecan·Tislelizumab
Zhejiang Provincial People's Hospital
Not applicable
94
Hangzhou
2025-07-01
Recruiting
Efficacy and Safety of Telitacicept Combined With Tofacitinib for Refractory Rheumatoid Arthritis
NCT06979271Telitacicept, Treatment Compliance, Rheumatoid Arthritis
Zhejiang Provincial People's Hospital
Observational
20
Hangzhou
2025-06-01
Not yet open
Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence
NCT06939400Glioblastoma Multiforme (GBM)
Zhejiang Provincial People's Hospital
Observational
100
Hangzhou
2025-06-01
Recruiting
Efficacy and Safety of Henagliflozin Proline and Metformin Hydrochloride Extended-release Tablets (Ⅰ) Versus Metformin Tablets in Patients With New-onset Type 2 Diabetes: a Multicenter, Randomized Controlled Study
NCT06888050New-onset Type 2 Diabetes
DrugMetformin
Zhejiang Provincial People's Hospital
Phase 4
268
Hangzhou
2025-04-11
Recruiting
A Clinical Study on Fasudil Hydrochloride for Treatment of Gene-Specific Ovarian Cancer
NCT06890858Ovarian Cancer
DrugFasudil Hydrochloride
Zhejiang Provincial People's Hospital
Phase 2
20
Hangzhou
2025-04
Recruiting
Drug-induced Kidney Injury Model
NCT06939387Acute Kidney Injury
Zhejiang Provincial People's Hospital
Observational
1,500
Hangzhou
2025-03-10
Recruiting
An Exploratory Study to Confirm Efficacy of Modified Deep Cervical Lymphovenous Anastomosis (LVA) in Alzheimer's Disease/ Parkinson's Disease
NCT06852352Alzheimer Disease, Parkinson Disease
Zhejiang Provincial People's Hospital
Not applicable
160
Hangzhou
2025-02-28
Not yet open
Clinical Study of NKG2D CAR-NK Combined with PD-1 Monoclonal Antibody in the Treatment of ATC
NCT06856278Anaplastic Throid Carcinoma
Zhejiang Provincial People's Hospital
Phase 1/2
30
Hangzhou
2025-02-22
Not yet open
Impact of Thyroid Treatment on Ovarian Function and Pregnancy Outcomes in Women with Differentiated Thyroid Cancer
NCT06845098Thyroid Gland
Zhejiang Provincial People's Hospital
Not applicable
300
Hangzhou
2025-02-20
Recruiting
An Exploratory Study on Gene Methylation Detection of Colorectal Cancer
NCT07033156CRC (Colorectal Cancer), Adenoma Colon
Zhejiang Provincial People's Hospital
Observational
450
Hangzhou
2024-12-24
Not yet open
The Effectiveness of Pharmaceutical Service for INPATDRP
NCT06674512Drug Related Problem
Zhejiang Provincial People's Hospital
Not applicable
220
Hangzhou
2024-12
Recruiting
Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer
NCT06722911Pancreatic Cancer Resectable
Zhejiang Provincial People's Hospital
Phase 2
57
Hangzhou
2024-11-15
By invitation
Evaluation of Clinical Efficacy and Prognosis in Patients With Hypertrophic Obstructive Cardiomyopathy Through Hemodynamic Modeling Reconstructed by CT
NCT06683872Hypertrophic Cardiomyopathy (HCM)
Zhejiang Provincial People's Hospital
Observational
200
Hangzhou
2024-08-01
Recruiting
Cilostazol vs. Aspirin in Acute Non-cardioembolic Stroke With Cerebral mIcrobleeds
NCT06530537Cerebral Microbleeds, Stroke
DrugsCilostazol·Aspirin
Zhejiang Provincial People's Hospital
Phase 3
848
Hangzhou
2024-07-18
Recruiting
Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study
NCT06534762NSCLC, SCLC, Colorectal Cancer, Pancreas Cancer
DrugMirabegron
Zhejiang Provincial People's Hospital
Phase 2
260
Hangzhou
2024-07-15
Recruiting
Deep Cervical Lymphatlc-Venous Anastomosis Surgery for the Treatment of Alzheimer's Disease: A Pilot Study (DIVA Study)
NCT06530732Alzheimer's Disease
DrugLecanemab
Zhejiang Provincial People's Hospital
Phase 3
60
Hangzhou
2024-07-01
Recruiting
Clinical Intervention of Idecalcitol Combined With Whey Protein Powder and Exercise for Sarcopenia
NCT06537115Sarcopenia
Zhejiang Provincial People's Hospital
Phase 4
450
Hangzhou, Huzhou, Taizhou, Zhoushan
2024-06-16
Recruiting
Fundus Optical coheRence Tomography Angiography Evaluation for Small-vessel Health in Cerebral Small Vessel Disease
NCT06431711Cerebral Small Vessel Diseases, Retinal Ischemia, Choroid; Injury
Zhejiang Provincial People's Hospital
Observational
2,400
Hangzhou
2024-04-01
Recruiting
Early Identification of Malignant Brain Edema in laRge Artery oCclusive Stroke After Endovascular Therapy (EMBRACE Study)
NCT06451887Endovascular Therapy, Brain Edema, Prediction Model, Ischemic Stroke
Zhejiang Provincial People's Hospital
Observational
1,950
Hangzhou
2024-04-01
Recruiting
Steroid Diabetes in Patients With Kidney Disease
NCT06161701Nephrotic Syndrome
Zhejiang Provincial People's Hospital
Observational
300
Hangzhou
2024-01-10
Recruiting
Dementia Risk Registry Across the Multidimensional Lifespan: A 10-Year Study
NCT06164262Cerebral Small Vessel Diseases, Dementia, Mixed, Health Behavior, Health Behavior, Risky
Zhejiang Provincial People's Hospital
Observational
1,000
Hangzhou
2024-01-01
Recruiting
Revascularization Effect on CSVD Burden in Carotid Artery Stenosis
NCT06031610Carotid Artery Stenosis, Cerebral Small Vessel Diseases
Zhejiang Provincial People's Hospital
Observational
1,000
Hangzhou
2023-06-10
Recruiting
Radiomics-based Malnutrition for Cervical Cancer.
NCT05709769Cervical Cancer, Malnutrition
Zhejiang Provincial People's Hospital
Observational
150
Hangzhou
2023-01-31
Recruiting
Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC
NCT05446467Head and Neck Squamous Cell Carcinoma
Zhejiang Provincial People's Hospital
Phase 2
80
Qingdao, Hangzhou, Ningbo, Tianjin, Wenzhou
2022-09-01
Rows per page Showing 1–31 of 31
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 September 2026. https://priyalifescience.com/clinical-trials-china/city/hangzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 31 of those studies with a site in Hangzhou that also match the filters currently applied.

How many clinical trials are recruiting in Hangzhou?

22 of the 31 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 6 have not yet opened recruitment, 0 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hangzhou), 31 studies
PhaseStudiesRecruitingShare
Observational131041.9%
Not applicable5216.1%
Phase 25416.1%
Phase 4329.7%
Phase 1/2216.5%
Phase 3226.5%
Phase EARLY_PHASE1113.2%

Most active sponsors

Lead sponsors with the most studies (Hangzhou)
Lead sponsorStudiesRecruiting
Zhejiang Provincial People's Hospital3122
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.